Description: In this session, morbidity and life expectancy trends are discussed. In addition, a case study in R on how to model the uncertainty associated with incidence of disability, disabled and active deaths and other terminations is presented.

Description: Companies with the intention of being the top, trusted source(s) in an information overloaded world.

Description: Support systems and new solutions to enable caregivers to deliver better care and reduce personal stress.

Description: Predictive Analytics and Epigenetics are two of the most impactful driving forces for the future of healthcare, precision medicine, and insurance. Learn why this is true, how if will change the way our industry operates, and how you can stay viable and contribute to the betterment of humanity while also protecting the actuarial profession from obsolescence. Learn how personalized medicine keying off genetic testing is saving life insurers big dollars. The only limit seems to be testing access for their insureds.

Description: The presenters will explore the long-term care insurance product and its impact on potential transactions. Discuss why the inherent risks of this product create challenges for buyers and sellers in this market.

Description: This interactive panel discussion will cover perspectives on:</p><ul><li>the evolution of AG51 requirements, including practical considerations for implementation</li><li>the general evolution of long-term care insurance regulation</li><li>how both the public and private sector can help invigorate sales of long-term care insurance

Description: Creating the complete view and management of the complex interactions between care providers, medicines and behavior.

Description: The hybrid Life/LTC and Life / Chronic Illness market is an exciting market that is in its relative infancy. There are many new companies that have just entered, or are considering entering, the hybrid market. Hybrid sales have grown tremendously over the past decade and are still going strong, with annual premium revenue estimated to be above $4 billion per year. The young issue ages for these products, relative to when LTC benefits are paid, means that the claim experience in the industry for these products is still very limited. Additionally, there are many moving parts to these products that present correlated risks and assumptions. The new entrants to the market, limited experience, and the interactions of risks create an environment equipped for vibrant discussions on the product structure, risks, assumptions, and considerations for modeling these hybrid products. The presenters would provide insight into each of these topics through a conceptual discussion, supported by observational data from case study projections and sensitivities.

Description: The interplay between technology and design to create safe, comfortable and thriving environments for aging in place and managing care costs.

Description: The 2020 Long-Term Care (LTC) Medical Symposium was a two-day conference that extracted the thinking of leading experts on historical and future trends that will influence LTC insurance (LTCI) claim expectations. The symposium focused on the ideas from experts outside of the LTCI industry for the explicit purpose of gathering fresh perspectives on the issues that LTCI companies face, such as expected timing of new claims onset, length of claim, life expectancy and cost of care. The 2020 symposium built on and complemented the first annual symposium held in 2018 and 2019. The focus in 2020 was on aging of the brain and how technology will impact the future of LTC caregiving. The symposium is not intended to quantify historical or future trends or to be prescriptive or specific about long-term care actuarial assumptions. Rather, the symposium aims to provide the long-term care actuary with environmental context for considering morbidity and other macro factors that may impact LTC experience in the long term.